Mirapex (pramipexole) for Parkinson's

August 1997

    The FDA just approved Mirapex (pramipexole) for Parkinson's. It's the first new drug for Parkinson's since Eldepryl (selegiline) was approved almost ten years ago.

    Mirapex is a dopamine agonist...similar to Permax (pergolide) and Parlodel (bromocriptine).

    Mirapex works at least as well as bromocriptine...and might cause fewer serious side effects. That's because Mirapex ISN'T an ergot derivative like Permax and Parlodel.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote